April 07, 2020
Article
Endocrinologists make can a difference in COVID-19 by restricting their use of glucocorticoids. According to an editorial published in the Endocrine Society’s Journal of Clinical Endocrinology & Metabolism, patients treated with glucocorticoids will be at higher risk for coronavirus disease 2019 (COVID-19), the infection caused by the novel coronavirus.